Abstract

NONO is an RBP upstream regulator of both STAT3 RNA and protein levels and function. It represents an important and clinically relevant promoter of growth and resistance of TNBCs. NONO is also therefore a potential therapeutic target in TNBC.

Authors	Kim, Seong-Jin; Ju, Jin-Sung; Kang, Myoung-Hee; Eun, Ji Won; Kim, Young Ha; Raninga, Prahlad V; Khanna, Kum Kum; Gyorffy, Balázs; Pack, Chan-Gi; Han, Hee-Dong; Lee, Hee Jin; Gong, Gyungyub; Shin, Yong; Mills, Gordon B; Eyun, Seong-Il; Park, Yun-Yong
Journal	THERANOSTICS
Pages	7974-7992
Volume	10
Date	1/07/2020
Grant ID	HI17C0380
Funding Body	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea
URL	http://www.ncbi.nlm.nih.gov/pubmed/?term=10.7150/thno.45037